CRH Medical continues to bring in the revenue in 2019, posting $30.5 million in second quarter revenues, up from $27.3 million in the same period last year.
GI & Endoscopy
Bausch Health subsidiary Salix Pharmaceuticals settled an intellectual property case against Teva Pharmaceuticals over Salix's ulcerative colitis drug Apriso.
Physicians Endoscopy and Capital Digestive Care entered into a strategic partnership Aug. 1, which saw the two companies form a management platform.
The American College of Gastroenterology, the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy outlined how reimbursement for the top 10 GI procedures in ASCcs will change under the CMS 2020 proposed rule.
Becker's ASC Review featured 12 GI physicians this month:
Advertisement
Spencer Dorn, MD, is the vice chief of gastroenterology at Chapel Hill-based University of North Carolina Health.
Here are four updates from gastroenterology companies from the past week:
Exact Sciences posted revenues of $199.9 million in the second quarter of 2019 and announced a $2.8 billion deal to acquire Genomic Health.
Exact Sciences posted second-quarter 2019 revenues of $199.9 million, a 94 percent year-over-year increase.
While Jamison, Pa.-based Physicians Endoscopy laid dormant for the first half of 2019, a June partnership kicked off the beginning of what could shape up to be a busy year for the gastroenterology-only ASC management company.